
Jake Minh Vu
Examiner (ID: 14384, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1094 |
| Issued Applications | 353 |
| Pending Applications | 146 |
| Abandoned Applications | 625 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13714055
[patent_doc_number] => 20170367982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 15/632885
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632885 | HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES | Jun 25, 2017 | Abandoned |
Array
(
[id] => 12702070
[patent_doc_number] => 20180125856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS
[patent_app_type] => utility
[patent_app_number] => 15/627391
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15627391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/627391 | USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS | Jun 18, 2017 | Abandoned |
Array
(
[id] => 14805951
[patent_doc_number] => 20190269585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => THICKENING AND ELONGATION OF KERATINOUS FIBERS
[patent_app_type] => utility
[patent_app_number] => 16/301928
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301928 | THICKENING AND ELONGATION OF KERATINOUS FIBERS | Jun 12, 2017 | Abandoned |
Array
(
[id] => 18259781
[patent_doc_number] => 11607467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology
[patent_app_type] => utility
[patent_app_number] => 15/611098
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3579
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611098 | Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology | May 31, 2017 | Issued |
Array
(
[id] => 11992340
[patent_doc_number] => 20170296495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'LIQUID DOSAGE FORMS OF SODIUM NAPROXEN'
[patent_app_type] => utility
[patent_app_number] => 15/591512
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4069
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591512 | Liquid dosage forms of sodium naproxen | May 9, 2017 | Issued |
Array
(
[id] => 12049907
[patent_doc_number] => 20170326252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'Nanoparticles for Delivery of Agents to Glioblastoma Tumors'
[patent_app_type] => utility
[patent_app_number] => 15/587407
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15384
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587407 | Nanoparticles for Delivery of Agents to Glioblastoma Tumors | May 4, 2017 | Abandoned |
Array
(
[id] => 11864654
[patent_doc_number] => 20170231940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Multiparticulate L-Carnitine And Nootropic Compositions And Related Methods'
[patent_app_type] => utility
[patent_app_number] => 15/586652
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5049
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586652 | Multiparticulate L-Carnitine And Nootropic Compositions And Related Methods | May 3, 2017 | Abandoned |
Array
(
[id] => 11850144
[patent_doc_number] => 20170224634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'STABLE CANNABINOID FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/499178
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27998
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499178
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/499178 | STABLE CANNABINOID FORMULATIONS | Apr 26, 2017 | Pending |
Array
(
[id] => 12022267
[patent_doc_number] => 20170312366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'PREVENTION OF DRUG-INDUCED ATRIO-VENTRICULAR BLOCK'
[patent_app_type] => utility
[patent_app_number] => 15/494932
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7495
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494932 | Prevention of drug-induced atrio-ventricular block | Apr 23, 2017 | Issued |
Array
(
[id] => 14926009
[patent_doc_number] => 20190298642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => HAIR COSMETIC
[patent_app_type] => utility
[patent_app_number] => 16/306358
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306358 | HAIR COSMETIC | Apr 20, 2017 | Abandoned |
Array
(
[id] => 11820668
[patent_doc_number] => 20170209605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/480116
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16193
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480116 | CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY | Apr 4, 2017 | Abandoned |
Array
(
[id] => 16563274
[patent_doc_number] => 10888621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Injectable tissue adhesive hydrogel including gamma-cyclodextrin and biomedical use thereof
[patent_app_type] => utility
[patent_app_number] => 15/475948
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5043
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15475948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/475948 | Injectable tissue adhesive hydrogel including gamma-cyclodextrin and biomedical use thereof | Mar 30, 2017 | Issued |
Array
(
[id] => 11977707
[patent_doc_number] => 20170281862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'INJECTABLE COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/469797
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7125
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469797
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469797 | INJECTABLE COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | Mar 26, 2017 | Pending |
Array
(
[id] => 17664154
[patent_doc_number] => 11357830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Nano-scale delivery device and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/449830
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10663
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449830
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449830 | Nano-scale delivery device and uses thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 17133620
[patent_doc_number] => 11135154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Medroxyprogesterone acetate injectable compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/081068
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8955
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081068 | Medroxyprogesterone acetate injectable compositions and methods of use | Mar 1, 2017 | Issued |
Array
(
[id] => 13852863
[patent_doc_number] => 10188136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Hydrophobin mimics: process for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 15/435055
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 39
[patent_no_of_words] => 21608
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435055
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435055 | Hydrophobin mimics: process for preparation thereof | Feb 15, 2017 | Issued |
Array
(
[id] => 11954788
[patent_doc_number] => 20170258939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Staining Composition'
[patent_app_type] => utility
[patent_app_number] => 15/422961
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8398
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15422961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/422961 | Staining composition | Feb 1, 2017 | Issued |
Array
(
[id] => 16341123
[patent_doc_number] => 20200305773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => DEVICE AND METHOD FOR ANALYTE SENSING WITH MICROPOROUS ANNEALED PARTICLE GELS
[patent_app_type] => utility
[patent_app_number] => 16/071252
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071252 | DEVICE AND METHOD FOR ANALYTE SENSING WITH MICROPOROUS ANNEALED PARTICLE GELS | Jan 19, 2017 | Abandoned |
Array
(
[id] => 11602361
[patent_doc_number] => 20170119661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'INJECTABLE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/409164
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5147
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409164
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409164 | INJECTABLE COMPOSITIONS | Jan 17, 2017 | Abandoned |
Array
(
[id] => 11742829
[patent_doc_number] => 20170196901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'COMBINATION DRUG THERAPIES FOR CANCER AND METHODS OF MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/405106
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9120
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15405106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/405106 | COMBINATION DRUG THERAPIES FOR CANCER AND METHODS OF MAKING AND USING THEM | Jan 11, 2017 | Abandoned |